Results 31 to 40 of about 74,557 (274)
Gonadotropin-Releasing Hormone and Its Role in the Enteric Nervous System
Frontiers in Endocrinology, 2017 Gonadotropin-releasing hormone (GnRH), follicle-stimulating hormone, and luteinizing hormone orchestrate the reproduction cycle and regulate the sex steroid secretion from the gonads.
Bodil Ohlsson, Bodil Ohlsson
doaj +1 more source
The use of GnRH analogs in preserving ovarian function during chemotherapy
Middle East Fertility Society Journal, 2021 Background The literature has always been controversial on the use of gonadotropin-releasing hormone agonists in preserving fertility in women of childbearing age after chemotherapy; thereby, in this article, we will be discussing its use in preserving ...
Omar M. Odeh +3 more
doaj +1 more source
Gonadotropin-Releasing Hormone Requirements for Ovulation1 [PDF]
Biology of Reproduction, 1997 This article addresses the role of GnRH in ovulation in the context of two general models of GnRH action--deterministic and permissive. According to the deterministic model, increased GnRH secretion is required to induce the preovulatory LH surge and thus ovulation. The permissive model, in contrast, holds that GnRH secretion need not increase. Rather,
Karsch, F.J. +4 more
openaire +4 more sources
Choosing trigger of ovulation for optimization of in vitro fertilization programs (literature review) [PDF]
Гинекология, 2016 This review presents recent data on the impact of different triggers on the clinical and embryological indicators of the effectiveness of assisted reproductive technology in patients with normal and excessive ovarian response to superovulation ...
S M Eapen +4 more
doaj
Gonadotropin-releasing hormone antagonists [PDF]
Current Opinion in Pharmacology, 2003 Hypothalamic gonadotropin-releasing hormone (GnRH) is a decapeptide that stimulates pituitary synthesis and secretion of gonadotropins and, therefore, gonadal hormones. GnRH antagonists, of which thousands have been formulated, inhibit the hormone from binding to its receptor, inducing a pharmacological hypophysectomy.
openaire +3 more sources
Effect of luteal phase support gonadotropin-releasing hormone agonist on the endometrial receptivity and outcomes of in vitro fertilization programs [PDF]
Гинекология, 2016 Patients with tubal infertility in implantation window period show impaired endometrial receptivity with low implantation potention that is characterized by decrease in mature pinopodes level on endometrium, decreased expression of leukemia inhibitory ...
E M Savelyeva +3 more
doaj
Morning basal luteinizing hormone, a good screening tool for diagnosing central precocious puberty [PDF]
Annals of Pediatric Endocrinology & Metabolism, 2019 Purpose The standard method used to diagnose central precocious puberty (CPP) is the gonadotropin releasing hormone stimulation test (GnRHST). However, this test is inconvenient for children because it is time-consuming and requires multiple samples ...
Dong-Min Lee, In-Hyuk Chung
doaj +1 more source
Frontiers in Endocrinology, 2022 ObjectiveTo investigate the efficacies of three cycle regimens in women receiving frozen embryo transfer with a history of cesarean section: natural cycle treatment, hormone replacement therapy and treatment with gonadotropin-releasing hormone agonist ...
Run Xin Gan +12 more
doaj +1 more source
pS6K1 as an efficacy marker of GnRH agonist with premenopausal breast cancer
Endocrine Connections, 2019 Estradiol is a key factor for tumorigenesis and prognosis of hormone receptor-positive breast cancer. Adipocytes are one source of estradiol in patients with breast cancer. Recent studies have shown that phosphorylated ribosomal protein S6 kinase-1 plays
Chan Sub Park +8 more
doaj +1 more source
Medicina, 2023 Background and objectives: Teverelix drug product (DP) is a gonadotropin-releasing hormone antagonist in development for the treatment of patients with prostate cancer in whom androgen deprivation therapy is indicated. The aim of this paper is to present
Carol M. MacLean +5 more
doaj +1 more source